These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27416043)

  • 21. The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis.
    Chen H; Wang H; Xu X; Hu Y; Su J; Li D; Li Z; Feng S; Liu J; Zhang H; Wang X
    Int Immunopharmacol; 2024 Jun; 134():112255. PubMed ID: 38744176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficiency of different enemas on patients with distal ulcerative colitis.
    Zhang Y; Chen D; Wang F; Li X; Xue X; Jiang M; Xu B; Chu Y; Wang W; Wu K; Mao R; Shen J; Yang S; Liang J
    Cell Prolif; 2019 Mar; 52(2):e12559. PubMed ID: 30659678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
    Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
    Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.
    Managlia E; Katzman RB; Brown JB; Barrett TA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2051-60. PubMed ID: 23867870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
    Harris MS; Lichtenstein GR
    Aliment Pharmacol Ther; 2011 May; 33(9):996-1009. PubMed ID: 21385194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
    Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
    Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of lipoic acid on caveolin-1-regulated antioxidative enzymes in the mouse model of acute ulcerative colitis.
    Piechota-Polanczyk A; Zielińska M; Piekielny D; Fichna J
    Biomed Pharmacother; 2016 Dec; 84():470-475. PubMed ID: 27685790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis.
    Wada H; Miyoshi J; Kuronuma S; Nishinarita Y; Oguri N; Hibi N; Takeuchi O; Akimoto Y; Lee STM; Matsuura M; Kobayashi T; Hibi T; Hisamatsu T
    Sci Rep; 2023 Jul; 13(1):12241. PubMed ID: 37507482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice.
    Chen L; Zhou Z; Yang Y; Chen N; Xiang H
    PLoS One; 2017; 12(10):e0186138. PubMed ID: 29049372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis.
    Cuffari C; Pierce D; Korczowski B; Fyderek K; Van Heusen H; Hossack S; Wan H; Edwards AY; Martin P
    Drug Des Devel Ther; 2016; 10():593-607. PubMed ID: 26893546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
    Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
    J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
    Goto M; Okamoto Y; Yamamoto M; Aki H
    J Pharm Pharmacol; 2001 Dec; 53(12):1711-20. PubMed ID: 11804402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis.
    Odze R; Antonioli D; Peppercorn M; Goldman H
    Am J Surg Pathol; 1993 Sep; 17(9):869-75. PubMed ID: 8352372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis.
    L'Heureux MC; Brubaker PL
    J Pharmacol Exp Ther; 2003 Jul; 306(1):347-54. PubMed ID: 12815012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
    Bosworth BP; Sandborn WJ; Rubin DT; Harper JR
    Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD; Das KM
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.